Literature DB >> 1312890

Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC).

H Yano1, M Maruiwa, A Iemura, A Mizoguchi, M Kojiro.   

Abstract

A new human extrahepatic bile duct carcinoma cell line (KMBC) was established from a serially transplanted tumor in nude mice that originated from a surgically resected tumor from a 73-year-old Japanese man; the cell line has been maintained for 5 five years. KMBC cells proliferate in a monolayered sheet with a population doubling time of 30 hours. Chromosome number was distributed in a range from 37 to 44, with modal numbers of 40 and 41. KMBC cells and the reconstituted tumor in a nude mouse showed moderately to poorly differentiated adenocarcinoma and possessed various functional characteristics of extrahepatic bile duct carcinoma. KMBC cells secreted carbohydrate antigen 19-9, tissue polypeptide antigen, carcinoembryonic antigen, ferritin, beta 2-microglobulin, fibronectin, and alpha 2-macroglobulin and produced glutamic oxaloacetic transaminase and alkaline phosphatase. KMBC is the second established cell line that originated from a human extrahepatic bile duct carcinoma in the world literature, and it will be applicable to various experiments.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312890     DOI: 10.1002/1097-0142(19920401)69:7<1664::aid-cncr2820690705>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma.

Authors:  Ayano Kabashima; Petra Hirsova; Steven F Bronk; Matthew C Hernandez; Mark J Truty; Sumera Rizvi; Scott H Kaufmann; Gregory J Gores
Journal:  J Hepatol       Date:  2018-03-09       Impact factor: 25.083

2.  Lysophosphatidylcholine suppresses apoptotic cell death by inducing cyclooxygenase-2 expression via a Raf-1 dependent mechanism in human cholangiocytes.

Authors:  G-Y Gwak; J-H Yoon; S-H Lee; S-M Lee; H-S Lee; G J Gores
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-29       Impact factor: 4.553

3.  The biliary epithelium presents antigens to and activates natural killer T cells.

Authors:  Elisabeth Schrumpf; Corey Tan; Tom H Karlsen; Jon Sponheim; Niklas K Björkström; Olav Sundnes; Kristian Alfsnes; Arthur Kaser; Douglas M Jefferson; Yoshiyuki Ueno; Tor J Eide; Guttorm Haraldsen; Sebastian Zeissig; Mark A Exley; Richard S Blumberg; Espen Melum
Journal:  Hepatology       Date:  2015-05-20       Impact factor: 17.425

4.  Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells.

Authors:  Yucel Ustundag; Steven F Bronk; Gregory J Gores
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

5.  Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100).

Authors:  Banchob Sripa; Saman Leungwattanawanit; Takayuki Nitta; Chaisiri Wongkham; Vajarabhongsa Bhudhisawasdi; Anucha Puapairoj; Chongrak Sripa; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

6.  Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation.

Authors:  Srimeenakshi Srinivasan; Ashish Yeri; Pike See Cheah; Allen Chung; Kirsty Danielson; Peter De Hoff; Justyna Filant; Clara D Laurent; Lucie D Laurent; Rogan Magee; Courtney Moeller; Venkatesh L Murthy; Parham Nejad; Anu Paul; Isidore Rigoutsos; Rodosthenis Rodosthenous; Ravi V Shah; Bridget Simonson; Cuong To; David Wong; Irene K Yan; Xuan Zhang; Leonora Balaj; Xandra O Breakefield; George Daaboul; Roopali Gandhi; Jodi Lapidus; Eric Londin; Tushar Patel; Robert L Raffai; Anil K Sood; Roger P Alexander; Saumya Das; Louise C Laurent
Journal:  Cell       Date:  2019-04-04       Impact factor: 41.582

7.  Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.

Authors:  Joachim C Mertens; Christian D Fingas; John D Christensen; Rory L Smoot; Steven F Bronk; Nathan W Werneburg; Michael P Gustafson; Allan B Dietz; Lewis R Roberts; Alphonse E Sirica; Gregory J Gores
Journal:  Cancer Res       Date:  2012-12-05       Impact factor: 12.701

8.  BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosis.

Authors:  Justin L Mott; Steve F Bronk; Ruben A Mesa; Scott H Kaufmann; Gregory J Gores
Journal:  Mol Cancer Ther       Date:  2008-08       Impact factor: 6.261

9.  Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.

Authors:  Sumera Rizvi; Joachim C Mertens; Steven F Bronk; Petra Hirsova; Haiming Dai; Lewis R Roberts; Scott H Kaufmann; Gregory J Gores
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

10.  A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma.

Authors:  Sumera Rizvi; Daisaku Yamada; Petra Hirsova; Steven F Bronk; Nathan W Werneburg; Anuradha Krishnan; Warda Salim; Liang Zhang; Eugenia Trushina; Mark J Truty; Gregory J Gores
Journal:  J Biol Chem       Date:  2016-01-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.